Hepatitis B Immune Globulin Terminated Phase 2 Trials for Viral Hepatitis B / Transplantation, Liver Prevention

IndicationsStatusPurposePhase
TerminatedPrevention2
clinicaltrials.gov IdentifierTitleDrugs
NCT00228592HepeX-B in Post Hepatic Allografts for Treatment of End Stage Liver Disease Due to Hepatitis B Infection